RSSS NASDAQ Week ended 24 Jul 2026

Weekly Investor Report

Research Solutions Inc · Technology · Software - Application

Open interactive chart View report data Download investor PDF
Latest close 2.20 USD
-0.5% latest week
Weekly setup

Weak trend

The weekly trend is not active. Price is -10.6% below the Trend Line and sits at 9.4% of its 52-week range. The latest completed week returned -0.5%, after a -3.9% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive. The latest news-sentiment score is 54/100. Near-term considerations: volume confirmation is below normal; earnings are due in 49d.

Setup score 21 out of 100
Latest Close 2.20 USD 24 Jul 2026
1W Return -0.5% latest completed week
4W Return -3.9% short-term follow-through
12W Return -16.3% quarterly tape
Trend Breadth 25.0% 13 of 52 weeks active
Volume Ratio 0.4x vs 13-week average
What is working
  • No strong opportunity cluster is confirmed yet; monitor trend and activity pressure.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Activity pressure is negative, which weakens the current setup.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through -0.5% Latest completed week; four-week move -3.9%. Indicator stack 14/31 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Recent Activity-pressure buy-signal status for institutional accumulation timing. News sentiment 54/100 38 relevant articles in the latest sentiment read. Event risk 49d Next report is scheduled for 17 Sep 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is -10.6% below the Trend Line and sits at 9.4% of its 52-week range. The latest completed week returned -0.5%, after a -3.9% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.4x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
30 Jan 6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.2312-week average 0.21

12-week confirmation

Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure10/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.23Current proprietary activity-pressure read.
Buy signals1Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -3.9% over four weeks, -16.3% over 12 weeks, and -20.3% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W-0.5%
4W-3.9%
12W-16.3%
26W-23.9%
52W-20.3%
Active trend streak0 weeks
Active weeks in one year13
Trend breadth25.0%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure-0.25Latest activity-pressure read.
Pressure change-182.1%Four-week change in activity pressure.
Leadership-27.25Latest relative-leadership reading.
RS change6.2%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 30 Jun 2025 Field coverage 88% Model confidence 84%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength48/100Blend of value, momentum, and quality. Underlying universe rank 53; rank 1 is best.
Value75/100Relative valuation strength. Underlying universe rank 26; rank 1 is best.
Quality28/100Profitability and accounting quality. Underlying universe rank 73; rank 1 is best.
Momentum16/100Medium-term price momentum. Underlying universe rank 85; rank 1 is best.
Growth25/100Revenue and earnings growth. Underlying universe rank 76; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
16.3x
Price divided by trailing earnings.
Price / sales
1.5x
Market value relative to trailing revenue.
EV / EBITDA
9.8x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
9.4%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
50.1%
Gross profit retained from each unit of revenue.
Operating margin
10.4%
Operating profit retained from revenue.
Free-cash-flow margin
11.9%
Free cash flow generated from revenue.
Return on invested capital
-
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
-0.2%
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-14.2%
Latest one-year free-cash-flow growth.
Piotroski F-score
5/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
-0.1%
Net share repurchases relative to market value.
Shareholder yield
-0.1%
Dividend yield plus net buyback yield.
Net debt / EBITDA
-1.9x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment54/100

Weighted news tone is neutral across 38 relevant articles.

9 positive · 28 neutral · 1 negative
Patient CapitalRecent

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

Recent buy signal in the last 8 weeks
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings49dNext report is scheduled for 17 Sep 2026; event risk rises as the date approaches.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-46.6%Distance below the 52-week high.
13-week volatility3.6%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher10 of 2614 weeks finished lower.
Best week+7.5%Week of 17 Apr.
Worst week-8.8%Week of 6 Feb.
Latest week-0.5%Week of 24 Jul.

Shape of recent returns

Strong gains2
Modest gains8
Flat weeks2
Modest losses9
Sharp losses5
Recent vol3.6%13-week weekly-return volatility.
Base vol4.5%52-week weekly-return volatility.
Up/down split22/28Count of positive and negative weeks in the 52-week window.
Average skew3.8% / -3.6%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape21/100

Trend, activity pressure, participation, and risk combine to a 21/100 tape read.

 Indicator analysis30/100

Latest 12-week confirmation: trend 0/12, activity pressure 10/12, relative leadership 0/12.

Activity pressure 0.23; No reversal markers Factors41/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 72; Small Cap Core rank 69 Patient CapitalRecent

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

Recent buy signal in the last 8 weeks Sentiment54/100

Weighted news tone is neutral across 38 relevant articles.

Research Solutions Inc (RSSS) Shareholder Structure: Major Shareholders & Institutional Holdings Insiders50/100

No recent insider transaction evidence is stored.

 Earnings49d

Next report is scheduled for 17 Sep 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
24 Jul 20262.20 USD-0.5%2.46 USD2.81 USD-0.25-27.25116.2KOff
17 Jul 20262.21 USD-4.3%2.48 USD2.81 USD-0.00-28.60131.4KOff
10 Jul 20262.31 USD0.0%2.51 USD2.81 USD0.17-28.98146.5KOff
3 Jul 20262.31 USD0.9%2.53 USD2.81 USD0.25-28.36146.6KOff
26 Jun 20262.29 USD0.0%2.55 USD2.81 USD0.31-29.04257.6KOff
19 Jun 20262.29 USD-1.7%2.58 USD2.81 USD0.24-32.80253.7KOff
12 Jun 20262.33 USD3.6%2.60 USD2.81 USD0.29-30.39356.6KOff
5 Jun 20262.25 USD3.2%2.63 USD2.81 USD0.39-31.82431.6KOff
29 May 20262.18 USD-3.1%2.66 USD2.81 USD0.42-37.44253.4KOff
22 May 20262.25 USD-5.9%2.69 USD2.80 USD0.57-34.20650.4KOff
15 May 20262.39 USD-8.1%2.73 USD2.80 USD0.49-29.95935.3KOff
8 May 20262.60 USD-1.1%2.75 USD2.80 USD0.33-24.75213.6KOff
1 May 20262.63 USD5.2%2.78 USD2.80 USD-0.02-20.53255.6KOff
24 Apr 20262.50 USD-3.5%2.81 USD2.79 USD-0.43-23.89209.9KOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.